000 | 01525 a2200433 4500 | ||
---|---|---|---|
005 | 20250515030233.0 | ||
264 | 0 | _c20060629 | |
008 | 200606s 0 0 eng d | ||
022 | _a0366-6999 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSun, Shu-zhen | |
245 | 0 | 0 |
_aEffects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats. _h[electronic resource] |
260 |
_bChinese medical journal _cMay 2006 |
||
300 |
_a814-21 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBenzazepines _xpharmacology |
650 | 0 | 4 |
_aBlood Glucose _xanalysis |
650 | 0 | 4 | _aBody Weight |
650 | 0 | 4 |
_aCollagen Type IV _xmetabolism |
650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xmetabolism |
650 | 0 | 4 |
_aDiabetic Nephropathies _xprevention & control |
650 | 0 | 4 |
_aKidney _xdrug effects |
650 | 0 | 4 |
_aKidney Glomerulus _xpathology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMatrix Metalloproteinase 2 _xanalysis |
650 | 0 | 4 | _aOrgan Size |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 | _aStreptozocin |
650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-2 _xanalysis |
700 | 1 | _aWang, Yi | |
700 | 1 | _aLi, Qian | |
700 | 1 | _aTian, Yong-jie | |
700 | 1 | _aLiu, Ming-hua | |
700 | 1 | _aYu, Yong-hui | |
773 | 0 |
_tChinese medical journal _gvol. 119 _gno. 10 _gp. 814-21 |
|
999 |
_c16330117 _d16330117 |